European journal of medicinal chemistry

Environment international

International journal of molecular sciences

Dalton transactions (Cambridge, England : 2003)

Theranostics

oncology letters

PLoS computational biology

oncotarget

Anticancer research

Cancer management and research

Biochemical and biophysical research communications

european journal of surgical oncology : the journal of the european society of surgical oncology and the british association of surgical oncology

Frontiers in oncology

Cell death & disease

Optics express

bju international

Asian Pacific journal of cancer prevention : APJCP

Aging

expert review of gastroenterology & hepatology

the oncologist

Cancer medicine

journal of cancer

Molecular and cellular biochemistry

ebiomedicine

helicobacter

cancer communications (london, england)

pharmacology & therapeutics

[1] Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer.

[2] Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer.

[3] Robotic versus open radical cystectomy for bladder cancer in adults.

[4] Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.

[5] The Pattern of Signatures in Gastric Cancer Prognosis.

[6] A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer.

[7] Fundamental steps toward next-generation intelligent automatic process in a faster and cost-effective chain for processing optical surfaces.

[8] Make Intelligent of Gastric Cancer Diagnosis Error in Qazvin's Medical Centers: Using Data Mining Method.

[9] Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: Design, synthesis and SAR studies.

[10] The Use of (Network) Meta-Analysis in Clinical Oncology.

[11] Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.

[12] Differentially expressed genes and are potential prognostic biomarkers for gastric cancer.

[13] Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer.

[14] Knockdown of serine/threonine-protein kinase 24 promotes tumorigenesis and myeloid-derived suppressor cell expansion in an orthotopic immunocompetent gastric cancer animal model.

[15] Trifluridine/Tipiracil for the Treatment of Metastatic Gastric Cancer.

[16] Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.

[17] AURKB promotes gastric cancer progression via activation of expression.

[18] Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456.

[19] HP-CagA+ Regulates the Expression of CDK4/CyclinD1 via to Change Cell Cycle and Promote Cell Proliferation.

[20] miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model.

[21] Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer.

[22] Exhaled breath analysis for gastric cancer diagnosis in Colombian patients.

[23] Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.

[24] Ribosomal DNA copy number is associated with P53 status and levels of heavy metals in gastrectomy specimens from gastric cancer patients.

[25] Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials

[26] epidemiology of helicobacter pylori and caga-positive infections and global variations in gastric cancer

[27] clinical utility of her2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

[28] male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after h. pylori infection

[29] relationship between tumor necrosis factor-α rs361525 polymorphism and gastric cancer risk: a meta-analysis

[30] fcγriia and iiia polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer

[31] recommendations for endoscopic and histological follow-up of patients with chronic gastritis and precancerous gastric lesions

[32] detouring the undesired route of helicobacter pylori-induced gastric carcinogenesis

[33] association between the microsatellite instability status and the efficacy of postoperative adjuvant chemoradiotherapy in patients with gastric cancer

[34] sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer

[35] association of vdr gene taqi polymorphism with the susceptibility to prostate cancer in asian population evaluated by an updated systematic meta-analysis

[36] prolonged survival in a case of chemotherapy-sensitive gastric cancer that produced alpha-fetoprotein and protein induced by vitamin k antagonist-ii

[37] efectividad de la premedicación con n-acetil cisteína más dimetilpolisiloxano versus un placebo para mejorar la visibilidad en la endoscopia digestiva: estudio prospectivo, ciego, controlado aleatorizado

[38] the impact of the extent of surgical resection on survival of gastric cancer patients

[39] effect of evodiamine on inducing apoptosis of human gastric cancer cell line sgc-7901 in vitro

[40] relationship of preoperative gastric cancer ct enhancement ratio and perfusion parameters with serum tumor marker levels and proliferation molecule expression in tumor lesions

[41] analysis of postoperative morbidity and mortality following surgery for gastric cancer. surgeon volume as the most significant prognostic factor

[42] enhanced cell survival of gastric cancer cells by a novel gene urg4

[43] the coexpression and prognostic significance of c-met, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

[44] clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study

[45] susceptibilidad genética y riesgo de cáncer gástrico en una población del cauca.

[46] outcomes of advanced gastric cancer in young adult patients treated with first-line combination chemotherapy

[47] relationship between s alleles of vaca gene of helicobacter pylori and gastroduodenal diseases in iran: a brief report

[48] lack of association between gastric cancer and hopq alleles in helicobacter pylori

[49] evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin c in locally advanced and metastatic gastric cancer

[50] asociación del polimorfismo del codon 72 del gen p53 con el riesgo de cáncer gástrico en una población de alto riesgo de costa rica

[51] platelet activation in patients after splenectomy with total gastrectomy for gastric cancer

[52] gastric cancer, nutritional status, and outcome

[53] helicobacter pylori: recent advances in the study of its pathogenicity and prevention

[54] an unusual presentation of metastatic gastric adenocarcinoma — acute onset of right neck swelling

[55] selective cdk7 inhibition with bs-181 suppresses cell proliferation and induces cell cycle arrest and apoptosis in gastric cancer

[56] proton pump inhibitors (ppis): the culprit for barrett’s esophagus?

[57] cyp2a6 polymorphisms associate with outcomes of s-1 plus oxaliplatin chemotherapy in chinese gastric cancer patients

[58] downregulation of stard8 in gastric cancer and its involvement in gastric cancer progression

[59] prognostic role of long non-coding rna hnf1a-as1 in chinese cancer patients: a meta-analysis

[60] EBV+ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8+ Intratumoral Lymphocytes

[61] First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

[62] Hereditary Diffuse Gastric Cancer: Prophylactic Surgical Oncology Implications

[63] Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer.

[64] Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control.

[65] Purified sulforaphane from broccoli (Brassica oleracea var. italica) leads to alterations of CDX1 and CDX2 expression and changes in miR-9 and miR-326 levels in human gastric cancer cells

[66] Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.

[67] Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties.

[68] Stagnation in Decreasing Gastric Cancer Incidence and Mortality in Quito: Time Trend Analysis, 1985–2013

[69] Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner.

[70] Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer

[71] Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer

[72] Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.

[73] Exosome-mediated transfer of CLIC1 contributes to the vincristine-resistance in gastric cancer.

[74] RAB13 as a novel prognosis marker promotes proliferation and chemotherapeutic resistance in gastric cancer.

[75] Extract of Cycas revoluta Thunb. Enhances the inhibitory effect of 5-fluorouracil on gastric cancer cells through the AKT-mTOR pathway

[76] EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer.

[77] Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer.

[78] Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.

[79] Physical recovery in the first six months following oesophago-gastric cancer surgery. Identifying rehabilitative needs: a qualitative interview study.

[80] The Pattern of Signatures in Gastric Cancer Prognosis.

[81] A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer.

[82] Make Intelligent of Gastric Cancer Diagnosis Error in Qazvin's Medical Centers: Using Data Mining Method.

[83] The Impact of the Disease Trend on the Macro and Micro-Nutrients Intake in Patients with Gastric Cancer.

[84] Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: Design, synthesis and SAR studies.

[85] MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals

[86] Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

[87] Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.

[88] Combination of Sodium Selenite and Doxorubicin Prodrug Ac-Phe-Lys-PABC-ADM Affects Gastric Cancer Cell Apoptosis in Xenografted Mice.

[89] Early diagnosis in gastric cancer: Pilot project

[90] A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer

[91] A Deep Learning Model for Cell Growth Inhibition IC50 Prediction and Its Application for Gastric Cancer Patients.

[92] Effect of hospital and surgeon volume on postoperative outcomes after distal gastrectomy for gastric cancer based on data from 145,523 Japanese patients collected from a nationwide web-based data entry system

[93] Asporin promotes cell proliferation via interacting with PSMD2 in gastric cancer.

[94] Differentially expressed genes and are potential prognostic biomarkers for gastric cancer.

[95] Knockdown of serine/threonine-protein kinase 24 promotes tumorigenesis and myeloid-derived suppressor cell expansion in an orthotopic immunocompetent gastric cancer animal model.

[96] Trifluridine/Tipiracil for the Treatment of Metastatic Gastric Cancer.

[97] [Clinical application of convolutional neural network in pathological diagnosis of metastatic lymph nodes of gastric cancer].

[98] Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.

[99] AURKB promotes gastric cancer progression via activation of expression.

[100] Anti-mitotic potential of 7-diethylamino-3 (2′-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU

[101] miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model.